Shares Outstanding (Quarterly) Chart

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
September 30, 2026 15.44M
June 30, 2026 15.30M
March 31, 2026 8.762M
December 31, 2025 8.68M
September 30, 2025 7.163M
June 30, 2025 4.855M
March 31, 2025 2.830M
December 31, 2024 1.506M
September 30, 2024 1.080M
June 30, 2024 0.6977M
March 31, 2024 0.5923M
December 31, 2023 0.5694M
September 30, 2023 0.5362M
June 30, 2023 0.4771M
March 31, 2023 0.4749M
December 31, 2022 0.4584M
September 30, 2022 0.4441M
June 30, 2022 0.4203M
March 31, 2022 0.3962M
Date Value
December 31, 2021 0.3553M
September 30, 2021 0.3245M
June 30, 2021 0.3243M
March 31, 2021 0.3203M
December 31, 2020 0.3122M
September 30, 2020 0.3111M
June 30, 2020 0.2493M
March 31, 2020 0.2472M
December 31, 2019 0.2138M
September 30, 2019 0.2138M
June 30, 2019 0.1507M
March 31, 2019 0.1502M
December 31, 2018 0.1434M
September 30, 2018 0.1261M
June 30, 2018 0.125M
March 31, 2018 0.1242M
December 31, 2017 0.1203M
March 31, 2017 0.1242M
December 31, 2016 0.1293M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
EyePoint, Inc. 90.77M
ANI Pharmaceuticals, Inc. 22.90M
Corcept Therapeutics, Inc. 109.36M
Veru, Inc. 17.05M
Johnson & Johnson 2.407B